Literature DB >> 18806054

Profound pain reduction after induction of memantine treatment in two patients with severe phantom limb pain.

Robert J Hackworth1, Kyle A Tokarz, Ian M Fowler, Scott C Wallace, Eric T Stedje-Larsen.   

Abstract

We present the cases of two patients who suffered severe lower extremity injuries and subsequently developed phantom limb pain (PLP) that was refractory to high dose opioids and adjunctive pain medications. Both patients were receiving large doses of oral methadone, IV hydromorphone via a patient-controlled analgesia delivery system, and adjunctive medications including tricyclic antidepressants, nonsteroidal anti-inflammatory medications, and anti-epileptics. Despite these treatments, the patients had severe PLP. Upon induction of the oral N-methyl-D-aspartate receptor antagonist memantine, both patients had a profound reduction in their PLP without any apparent side effects from the medication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806054     DOI: 10.1213/ane.0b013e31817f90f1

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  16 in total

Review 1.  A review of current theories and treatments for phantom limb pain.

Authors:  Kassondra L Collins; Hannah G Russell; Patrick J Schumacher; Katherine E Robinson-Freeman; Ellen C O'Conor; Kyla D Gibney; Olivia Yambem; Robert W Dykes; Robert S Waters; Jack W Tsao
Journal:  J Clin Invest       Date:  2018-06-01       Impact factor: 14.808

Review 2.  The narcotic bowel syndrome: a recent update.

Authors:  Douglas Drossman; Eva Szigethy
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

Review 3.  Narcotic bowel syndrome and opioid-induced constipation.

Authors:  Eva Szigethy; Marc Schwartz; Douglas Drossman
Journal:  Curr Gastroenterol Rep       Date:  2014-10

Review 4.  Coping with Phantom Limb Pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

5.  Changes in metabolites in the brain of patients with fibromyalgia after treatment with an NMDA receptor antagonist.

Authors:  Nicolas Fayed; Barbara Oliván; Yolanda Lopez Del Hoyo; Eva Andrés; Mari Cruz Perez-Yus; Alicia Fayed; Luisa F Angel; Antoni Serrano-Blanco; Miquel Roca; Javier Garcia Campayo
Journal:  Neuroradiol J       Date:  2019-06-19

6.  Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?

Authors:  Jill M Recla; Constantine D Sarantopoulos
Journal:  Med Hypotheses       Date:  2009-04-10       Impact factor: 1.538

7.  Current and future options for the management of phantom-limb pain.

Authors:  Helena Knotkova; Ricardo A Cruciani; Volker M Tronnier; Dirk Rasche
Journal:  J Pain Res       Date:  2012-03-07       Impact factor: 3.133

8.  Antinociceptive Effect of Memantine and Morphine on Vincristine-induced Peripheral Neuropathy in Rats.

Authors:  Byoung Yoon Park; Sang Hee Park; Woong Mo Kim; Myung Ha Yoon; Hyung Gon Lee
Journal:  Korean J Pain       Date:  2010-08-26

9.  Phantom limb pain: mechanisms and treatment approaches.

Authors:  Bishnu Subedi; George T Grossberg
Journal:  Pain Res Treat       Date:  2011-08-14

10.  Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up.

Authors:  Bárbara Olivan-Blázquez; Marta Puebla; Bárbara Masluk; Mari-Cruz Pérez-Yus; Raquel Arcega; Eva Andrés; Yolanda López-del-Hoyo; Rosa Magallon; Miquel Roca; Javier Garcia-Campayo
Journal:  Trials       Date:  2013-01-03       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.